Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV-IMPACT: ACT for CMV Reactivation Post-HSCT
NCT01077908Phase 3Completed
- Sponsor
- Kuur Therapeutics
- Start
- Jul 2008
- Primary completion
- Sep 2014
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of Cytovir in cytomegalovirus infection (CMV), sponsored by Kuur Therapeutics. Started Jul 2008; status: completed.
02
Drugs
Cytovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01077908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077908.